You have 9 free searches left this month | for more free features.

City

Graz (1)

Houston (1)

Innsbruck (1)

Linz (1)

Salzburg (1)

Vienna (1)

Condition

Leukemia (1)

Lymphoma of Mucosa-Associated Lymphoid Tissue (1)

Overall Status

Completed (2)

Phase

phase 2 (2)

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie (1)

M.D. Anderson Cancer Center (1)

Collaborator

Hoffmann-La Roche (1)

Lipomed (1)

Intervention

2-cda (2)

ara-c (1)

g-csf (granulocyte colony-stimulating factor) (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

2-cda

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma of Mucosa-Associated Lymphoid Tissue Trial in Austria (Rituximab, 2-CdA)

Completed

Lymphoma of Mucosa-Associated Lymphoid Tissue

Rituximab
2-CdA

Graz, Austria
+4 more

Dec 23, 2013

Leukemia Trial in Houston (2-CdA, Ara-C, G-CSF (Granulocyte colony-stimulating factor))

Completed

Leukemia

2-CdA
+2 more

Houston, Texas

U.T.M.D. Anderson Cancer Center

Aug 1, 2012